8-K current report · filed Nov 4, 2026

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) 8-K Current Report: November 4, 2026

Item 2.02Item 5.02Item EX-99.1CLOV overview

Short answer

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 results announcement for quarter ended September 30, 2026.

CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 results announcement for quarter ended September 30, 2026
  • Full financial results and management commentary available in Exhibit 99.1
  • Investor focus: earnings trajectory, medical-cost trends, membership, and cash position in the accompanying release

Item 5.02 · Departure/Election of Directors or Officers

  • Permanent CFO appointment effective November 4, 2026, ending interim status since March 30, 2026
  • Thornton compensation: $450,000 base salary, bonus target up to 75% of base salary
  • Thornton promotional RSU grant valued at $1,500,000, subject to approval and multi-year vesting
  • Oldakowski appointed Chief Accounting Officer effective November 4, 2026
  • Oldakowski compensation: $410,000 base salary, bonus target up to 50% of eligible earnings, plus $850,000 RSU grant value

Item EX-99.1 · Exhibit EX-99.1

  • Q3 GAAP net income $6.4M, versus $(24.4)M loss, bringing nine-month profit to $61.8M
  • Revenue $759.3M, up 52.9%, with Medicare Advantage membership up 46.3% to 158,383
  • Gross profit $129.8M, up 77.3%, and Adjusted EBITDA $16.1M versus $2.1M
  • Insurance BER improved to 91.1% from 93.5%, indicating better medical-cost performance despite rapid growth
  • 2026 guidance raised: revenue $2.97B-$3.00B, GAAP net income $25M-$35M, Adjusted EBITDA $75M-$85M
  • Flagship PPO, representing ~98% of membership, earned a 5 Star rating for Payment Year 2028, supporting 2027 enrollment momentum and potential economics

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K filings

Get the next CLOV 8-K as it lands

Follow CLOV for push alerts, or ask the research agent what this filing means.